Evidence map›Paper›PMID 38053181›Full record

ArticleBMC medicine2023

Association between viral infections and glioma risk: a two-sample bidirectional Mendelian randomization analysis.

Sheng Zhong, Wenzhuo Yang, Zhiyun Zhang, Yangyiran Xie, Lin Pan, Jiaxin Ren, Fei Ren, Yifan Li, Haoqun Xie, Hongyu Chen and 11 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 2 countries.

Sheng Zhong *State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Wenzhuo Yang *State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Zhiyun Zhang *Department of Plastic Surgery, The First Hospital of Jilin University, Changchun, 130000, People's Republic of China.
Yangyiran Xie *Vanderbilt University School of Medicine, Vanderbilt University, 1161 21St Ave S # D3300, Nashville, TN, 37232, USA.
Lin Pan *Clinical College, Jilin University, Street Xinmin 828, Changchun, People's Republic of China.
Jiaxin RenStroke Center, Department of Neurology, The First Hospital of Jilin University, Chang Chun, People's Republic of China.
Fei RenClinical College, Jilin University, Street Xinmin 828, Changchun, People's Republic of China.
Yifan LiState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Haoqun XieState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Hongyu ChenState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Davy DengDana Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.
Jie LuState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Hui LiStroke Center, Department of Neurology, The First Hospital of Jilin University, Chang Chun, People's Republic of China.
Bo WuDepartment of Orthopaedics, The First Hospital of Jilin University, No.71, Street Xinmin Road, Chaoyang District, Changchun, Jilin, People's Republic of China.
Youqi ChenClinical College, Jilin University, Street Xinmin 828, Changchun, People's Republic of China.
Fei PengDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, Houston, TX, USA.
Vinay K PuduvalliDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ke SaiState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. saike@sysucc.org.cn.
Yunqian LiDepartment of Neurosurgery, The First Hospital of Jilin University, Changchun, People's Republic of China. yunqian@jlu.edu.cn.
Ye ChengDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China. chengye@xwhosp.org.
Yonggao MouState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. mouyg@sysucc.org.cn.
Jilin University · CNSun Yat-sen University · CNSun Yat-sen University Cancer Center · CNFirst Hospital of Jilin University · CNBaylor College of Medicine · USCapital Medical University · CNDana-Farber Cancer Institute · USThe University of Texas MD Anderson Cancer Center · USVanderbilt University · US

Funding

Applied Basic Research Foundation of Guangdong ProvinceGuangdong Province 2021A1515111198Beijing New-star Plan of Science and Technology Z201100006820148National Natural Science Foundation of China 81872324
6 · The paper itself

Abstract

backgroundGlioma is one of the leading types of brain tumor, but few etiologic factors of primary glioma have been identified. Previous observational research has shown an association between viral infection and glioma risk. In this study, we used Mendelian randomization (MR) analysis to explore the direction and magnitude of the causal relationship between viral infection and glioma.

methodsWe conducted a two-sample bidirectional MR analysis using genome-wide association study (GWAS) data. Summary statistics data of glioma were collected from the largest meta-analysis GWAS, involving 12,488 cases and 18,169 controls. Single-nucleotide polymorphisms (SNPs) associated with exposures were used as instrumental variables to estimate the causal relationship between glioma and twelve types of viral infections from corresponding GWAS data. In addition, sensitivity analyses were performed.

resultsAfter correcting for multiple tests and sensitivity analysis, we detected that genetically predicted herpes zoster (caused by Varicella zoster virus (VZV) infection) significantly decreased risk of low-grade glioma (LGG) development (OR = 0.85, 95% CI: 0.76-0.96, P = 0.01, FDR = 0.04). No causal effects of the other eleven viral infections on glioma and reverse causality were detected.

conclusionsThis is one of the first and largest studies in this field. We show robust evidence supporting that genetically predicted herpes zoster caused by VZV infection reduces risk of LGG. The findings of our research advance understanding of the etiology of glioma.

Indexed as

GliomaHerpes ZosterVirus DiseasesGenome-Wide Association StudyHumansMendelian Randomization AnalysisGliomaMendelian randomizationRiskViral infection

Identifiers

PMID38053181
PMCPMC10698979
OpenAlexW4389348761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.